New Delhi: Pharmaceutical giants Sun Pharmaceutical Industries and Ranbaxy Laboratories Ltd have decided to collaborate in their functions. Both of them have entered into definitive agreements regarding this. According to this, Sun Pharma will acquire 100% of Ranbaxy in an all-stock transaction. In other words, the Sun Pharma is going to acquire Ranbaxy Pharmaceutical for a transaction of $4 billion.
The combination of Sun Pharma and Ranbaxy will result the rise of a fifth-largest specialty generics company in the world while in India, they come up as the largest pharmaceutical company.
The proposed transaction has been unanimously approved by the Boards of Directors of Sun Pharma, Ranbaxy, and Ranbaxy’s controlling shareholder, Daiichi Sankyo. Ranbaxy’s board and Sun Pharma’s board have recommended the approval of transactions to their respective shareholders.

Video on Sun Pharmaceuticals